| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.006 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |